Top compounds associated with response to TRABD2B


Feature Type Standardized
Nominal ANOVA
mRNA Bexarotene CTRPv2 pan-cancer AAC -0.046 0.2
mRNA BRD-A02303741 CTRPv2 pan-cancer AAC -0.049 0.2
mRNA Vandetanib CCLE pan-cancer AAC 0.06 0.2
mRNA SB-225002 CTRPv2 pan-cancer AAC 0.039 0.2
mRNA TAE684 CTRPv2 pan-cancer AAC 0.044 0.2
mRNA doxorubicin:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.041 0.2
mRNA Cytarabine CTRPv2 pan-cancer AAC 0.036 0.2
mRNA AEW541 CCLE pan-cancer AAC -0.058 0.2
mRNA CAY10576 CTRPv2 pan-cancer AAC -0.049 0.2
mRNA pac-1 CTRPv2 pan-cancer AAC -0.045 0.2
Download CSV